The case had threatened to restrict access to mifepristone across the country, including in states where abortion remains legal.

The Biden Administration is partnering with Danco, the drug maker of Mifepristone, to challenge the ruling from the Fifth Circuit Court of Appeals that puts significant restrictions on access to Mifepristone.